Date(s) - March 08, 2013
8:00 am - 10:30 am
HEALTH CARE CAPITAL FORUM
Six Emerging Growth Companies & Industry Investor Panel
The capital forum provides an opportunity to meet capital providers and businesses seeking capital, as well as to hear a panel of industry experts discuss financing alternatives for health care businesses.
Mobile Health OneMobile Health One, Inc. develops mobile, on-demand HIPAA-compliant systems that unify healthcare professionals within and between organizations by simplifying communications to accelerate, consolidate, and control information sharing. Adhere TechAdhereTech has created patented smart pill bottles that increase medication adherence. These bottles measure the exact number of pills or liquid in the bottle in real-time, wirelessly send this HIPAA-compliant data into the cloud, and remind patients to take their medication via phone call or text.
First Wave Technologies
First Wave Technologies Inc. is a medical device facilitation business, with two initial products, the First Crush automated pill crusher in order to make them digestible due to the high demand by the growing population of senior citizens; and a respiratory device conversion and amplification technology that turns a ventilator into the equivalent of a $150,000 anesthesia machine.
Raland Therapeutics, Inc. has developed diagnostic and therapeutic devices that use implantable biosensors to provide real time, in-vivo monitoring of biological signaling and cellular responses while minimizing animal handling, labor requirements, cell culture/pathologic processing and capital costs.
Venus Pharmaceuticals International
Venus Pharmaceuticals International, Inc., a well-established pharmaceuticals manufacturer, has developed a proprietary photo-bioreactor technology to grow, harvest, and dry/extract micro-algae indoors, contaminant free.
CytoSorbents Corporation is a critical care-focused therapeutics company using blood purification filters to control excessive, potentially deadly inflammation that could otherwise cause the failure of vital organs.
Paul Smolevitz: Paul Smolevitz is a Managing Director and was a founding partner of TM Capital Corp., a leading venture capital firm. Since 1989, he has led TM Capital’s execution of many complex transactions, including financings, strategic acquisitions, restructurings and fairness opinions. Previously, Paul served as a Vice President at Thomson McKinnon Securities Inc. and as a Senior Accountant at Deloitte & Touche. He is a graduate of the Wharton School of the University of Pennsylvania and earned an MBA from the Harvard Business School.Sponsor this event (Breakfast Sponsor)
Bookings are closed for this event.